🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)

Recruitingn/aAges 18 Years - 100 YearsAllMcMaster University
NCT06844227 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of the PAUSE-Virtual Study is to show that by changing pre-surgery visits with patients taking a blood thinner (direct oral anticoagulant (apixaban, dabigatran, edoxaban, rivaroxaban or warfarin) when the participant requires elective surgery, using a standard, in-person proven approach, to a virtual visit, either telephone or video conference, is as safe. Patients who are receiving a blood thinner for the medical condition known as atrial fibrillation (AF) and require an elective surgery/procedure, is common. These patients have to stop taking their blood thinner for a certain time before the procedure to reduce serious complications of stroke or bleeding. For doctors who help manage these patients before a procedure, appointments have been traditionally done in-person. Patients receive instructions about when to stop and restart their blood thinners and taught how to self-a

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 18 years of age or older with AF/flutter (chronic, persistent, paroxysmal) that requires anticoagulation * Receiving warfarin, with a target international normalized ratio (INR) range of 2.0-3.0, or a DOAC, comprising one of the following regimens: apixaban, 2.5 mg or 5 mg bid; edoxaban, 30 mg or 60 mg daily; dabigatran, 110 mg or 150 mg bid; or rivaroxaban, 15 mg or 20 mg daily * Require an elective (planned, non-urgent) surgery or invasive medical or surgical procedure Exclusion Criteria: * Indication for anticoagulation is not AF/flutter (e.g., mechanical heart valve, VTE, other) * Non-standard anticoagulant regimen used (e.g., warfarin INR 3-4, rivaroxaban 2.5 mg bid) * In DOAC users only: creatinine clearance \<25 mL/min (that preclude DOAC use) * Cognitive impairment or psychiatric illness (that precludes reliable contact during follow-up) * Unable or unwilling to provide consent for virtual care (in-person care will be provided) * Previous participation in this study for an elective surgery/procedure
💊

What it tests

  • Not listed
📍

Where

10 sites
Endeavor Health - Northshore
Evanston, United States
Henry Ford
Detroit, United States
Northwell Health
Great Neck, United States
Thomas Jefferson University Hospital
Philadelphia, United States
QEII Health Sciences Centre
Halifax, Canada
Hamilton General Hospital
Hamilton, Canada
St. Joesph's Healthcare
Hamilton, Canada
Juravinski
Hamilton, Canada

…and 2 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy